Share
Market Research Report

LIQUID BIOPSY-GUIDED THERAPY SWITCHING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Biomarker TypeESR1 Mutations · EGFR Mutations · KRAS Mutations · Other Actionable Biomarkers
  • By Liquid Biopsy TechnologyNext-Generation Sequencing (NGS) · Digital PCR (dPCR/ddPCR) · PCR-Based Assays
  • By Cancer TypeBreast Cancer · Lung Cancer · Colorectal Cancer · Others
  • By Therapy Switching ApproachSwitching Treatment Before Clinical Progression Based on Molecular Resistance · Switching Treatment at Clinical or Radiographic Progression · Switching Treatment Based on Molecular Response or Emerging Biomarkers
  • By End UserHospitals and Oncology Centers · Diagnostic and Reference Laboratories · Pharmaceutical and Biotechnology Companies · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In29 Oct 2026
  • Report CodeCMI10313
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Liquid Biopsy-Guided Therapy Switching Market, By Biomarker Type
      • Global Liquid Biopsy-Guided Therapy Switching Market, By Liquid Biopsy Technology
      • Global Liquid Biopsy-Guided Therapy Switching Market, By Cancer Type
      • Global Liquid Biopsy-Guided Therapy Switching Market, By Therapy Switching Approach
      • Global Liquid Biopsy-Guided Therapy Switching Market, By End User
      • Global Liquid Biopsy-Guided Therapy Switching Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Biomarker Type Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Industry Trends
  4. Global Liquid Biopsy-Guided Therapy Switching Market, By Biomarker Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • ESR1 Mutations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • EGFR Mutations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • EGFR Mutations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Other Actionable Biomarkers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Liquid Biopsy-Guided Therapy Switching Market, By Liquid Biopsy Technology, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Next-Generation Sequencing (NGS)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Digital PCR (dPCR/ddPCR)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • PCR-Based Assays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Liquid Biopsy-Guided Therapy Switching Market, By Cancer Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Colorectal Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Liquid Biopsy-Guided Therapy Switching Market, By Therapy Switching Approach, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Switching Treatment Before Clinical Progression Based on Molecular Resistance
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Switching Treatment at Clinical or Radiographic Progression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Switching Treatment Based on Molecular Response or Emerging Biomarkers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global Liquid Biopsy-Guided Therapy Switching Market, By End User, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals and Oncology Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Diagnostic and Reference Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  9. Global Liquid Biopsy-Guided Therapy Switching Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Liquid Biopsy Technology, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Switching Approach, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • Guardant Health, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Foundation Medicine, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Labcorp Holdings Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Tempus AI, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Caris Life Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • NeoGenomics Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • QIAGEN N.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Exact Sciences Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on Liquid Biopsy-Guided Therapy Switching Market' - Global forecast to 2033